Felbamate is reserved for severe, refractory seizures due to its risk of aplastic anemia and liver failure. Patients receiving felbamate require careful monitoring of both drug levels and hematologic and hepatic function.
This test is used to confirm therapeutic blood levels, evaluate suspected toxicity, guide dose adjustments, and assess compliance. Trough samples are typically most informative. Sample type is serum.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment